Pre-Open Stock Movers 03/15: (CPXX) (SZYM) (ESI) Higher; (VRX) (LINE) (DDD) Lower (more...)

March 15, 2016 9:36 AM EDT Send to a Friend

Celator Pharmaceuticals, Inc. (Nasdaq: CPXX) 409.5% HIGHER; announced positive results from the Phase 3 trial of VYXEOS (cytarabine: daunorubicin) Liposome ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Pre-Open Stock Movers 03/15: (CPXX) (SZYM) (ESI) Higher; (VRX) (LINE) (DDD) Lower (more...)

Member Login

Free News Feed